Breast cancer prevention

Climacteric

Volumn 10, Issue SUPPL. 2, 2007, Pages 47-53

  Russo, J ^a   Balogh, G ^a   Russo, I H ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

Breast cancer; Prevention

Indexed keywords

BIOLOGICAL MARKER; RECOMBINANT CHORIONIC GONADOTROPIN;

APOPTOSIS; ASPIRATION BIOPSY; BLOOD SAMPLING; BREAST CANCER; BREAST EPITHELIUM; CANCER PREVENTION; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CELL POPULATION; CHEEK MUCOSA; CONFERENCE PAPER; DNA MICROARRAY; DNA REPAIR; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE AMPLIFICATION; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; HUMAN; IMMUNE RESPONSE; NONHUMAN; POLYMERASE CHAIN REACTION; POSTMENOPAUSE; PREGNANCY; PRIORITY JOURNAL; RNA ISOLATION; RNA PROCESSING; STEM CELL;

BREAST; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CELL DIFFERENTIATION; CELL TRANSFORMATION, NEOPLASTIC; DISEASE SUSCEPTIBILITY; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITHELIAL CELLS; FEMALE; HUMANS; MIDDLE AGED; MOUTH MUCOSA; PARITY; POSTMENOPAUSE; PREGNANCY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; STEM CELLS;

EID: 34548819369     PISSN: 13697137     EISSN: 14730804     Source Type: Journal    
DOI: 10.1080/13697130701606762     Document Type: Conference Paper

References (26)

1. Dunn BK, McCaskill-Stevens W, Kramer B, Ford LG. Chemoprevention of breast cancer: The NSABP's breast cancer prevention trial. J Women's Cancer 2000;2:177-91
2. Daidone MG, Silvestrini R. Prognostic and predictive role of proliferation indices in adjuvant therapy of breast cancer. J Natl Cancer Inst Monographs 2001;30:27-35
3. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2006. CA Cancer J Clin 2006;56:106-30
4. Lynch HT, Casey MJ. Current status of prophylactic surgery for hereditary breast and gynecologic cancers. Curr Opin Obstet Gynecol 2001;13:25-30
5. McGregor DH, Land CE, Choi K, et al. Breast cancer incidence among atomic bomb survivors, Hiroshima and Nagasaki 1950-1989. J Natl Cancer Inst 1977;59:799-811
6. Clemona M, Loijens L, Goss P. Breast cancer risk following irradiation for Hodgkin's disease. Cancer Treat Rev 2000;26:291-302
7. MacGregor Schafer JI, Jordan VC. Antiestrogens for breast cancer prevention. J Women's Cancer 2000;2:145-52
8. Will BP, Nobrega KM, Berthelot JM, et al. First do no harm: extending the debate in provision of preventive tamoxifen. Br J Cancer 2001;85:1280-8
9. Santen RJ, Harvey HA. Use of aromatase inhibitors in breast carcinoma. J Women's Cancer 2000;2:121-34
10. MacMahon B, Cole P, Lin TM, et al. Age at first birth and breast cancer risk. Bull Natl Hlth Org 1970;43:209
11. Lambe M, Hseih CC, Chan HW, Ekbom A, Trichopoulous D, Adami HO. Parity age at first and last birth, and risk of breast cancer. A population-based study in Sweden. Breast Cancer Res Treat 1996;38:305-11
12. de Waard F, Thijssen JH. Hormonal aspects in the causation of human breast cancer: epidemiological hypotheses reviewed, with special reference to nutritional status and first pregnancy. J Steroid Biochem Mol Biol 2005;97:451-8
13. MacMahon B. Epidemiology and the causes of breast cancer. Forum Int J Cancer 2006;118:2373-8
14. Russo IH, Koszalka M, Russo J. Comparative study of the influence of pregnancy and hormonal treatment on mammary carcinogenesis. Br J Cancer 1991;64:481-4
15. Russo IH, Koszalka M, Russo J. Human chorionic gonadotropin and rat mammary cancer prevention. J Natl Cancer Inst 1990;82:1286-9
16. Russo IH, Russo J. Role of hCG and inhibin in breast cancer (Review). Int J Oncol 1994;4:297-306
17. Bernstein L, Hanisch R, Sullivan-Halley J, Ross RK. Treatment with human chorionic gonadotropin and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 1995;4:437-40
18. Russo J, Russo IH. Human chorionic gonadotropin in breast cancer prevention. In Ethier SP, ed. Endocrine Oncology. Totowa, NJ: Humana Press Inc., 2000:121-36
19. Srivastava P, Russo J, Russo IH. Chorionic gonadotropin inhibits mammary carcinogenesis through activation of programmed cell death. Carcinogenesis 1997;18:1799-808
20. Srivastava P, Russo J, Russo IH. Inhibition of rat mammary tumorigenesis by human chorionic gonadotropin is associated with increased expression of inhibin. Mol Carcinog 1999;26:10-19
21. Russo IH, Slater C, Lareef MH, et al. Recombinant human chorionic gonadotropin (r-hCG) reduces the incidence and progression of mammary tumors in the rat. Breast Cancer Res Treat 2000;64:50 (160a)
22. Russo J, Janssens J, Russo IH. Recombinant human chorionic gonadotropin (r-hCG) significantly reduces primary tumor cell proliferation in patients with breast cancer. Breast Cancer Res Treat 2000;64:51 (161a)
23. Balogh GA, Heulings R, Mailo DA, et al. Genomic signature induced by pregnancy in the human breast. Int J Oncol 2006;28:399-410
24. Russo J, Balogh GA, Chen J, et al. The concept of stem cell in the mammary gland and its implication in morphogenesis, cancer and prevention. Frontiers Biosci 2006;11:151-72
25. Russo J, Balogh GA, Heulings R, et al. Molecular basis of pregnancy induced breast cancer protection. Eur J Cancer Prevention 2006;15:306-42
26. The uniform approach to breast fine-needle aspiration biopsy. National Cancer Institute Fine Needle Aspiration of Breast Workshop Subcommittees. Diagn Cytopathol 1997;16:295-311